z-logo
open-access-imgOpen Access
SGLT‐2抑制剂在射血分数降低或保持不变的心力衰竭患者中是否显示出类似的心血管益处?
Author(s) -
Singh Awadhesh Kumar,
Singh Ritu,
Misra Anoop
Publication year - 2021
Publication title -
journal of diabetes
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.949
H-Index - 43
eISSN - 1753-0407
pISSN - 1753-0393
DOI - 10.1111/1753-0407.13182
Subject(s) - medicine , ejection fraction , heart failure , diabetes mellitus , cardiology , endocrinology
摘要 SGLT‐2抑制剂(SGLT‐2i)对心力衰竭患者的心血管有益已为人所知。SGLT‐2i在射血分数降低或保持不变的心力衰竭患者中是否具有类似的心血管效应尚不清楚。这项 meta 分析显示SGLT‐2i与心力衰竭的类型无关具有相似的心血管益处。未来的试验将证实或驳斥SGLT‐2i对射血分数保持不变的心力衰竭患者的心血管效应。

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom